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Abstract 
 Prion diseases are associated with the misfolding of the prion protein (PrP) from its 
normal cellular form (PrPC) to its infectious scrapie form (PrPSc). Posttranslational modifications 
of PrP in vivo can play an important role in modulating the process of misfolding. To gain more 
insight into the effects of posttranslational modifications on PrP structure and dynamics and to 
test the hypothesis that such modifications can interact with the protein, we have performed 
molecular dynamics simulations of diglycosylated human PrPC bound to a lipid bilayer via a 
glycophosphatidylinositol anchor. Multiple simulations were performed at three different pH 
ranges to explore pH effects on structure and dynamics. In contrast to simulations of protein-only 
PrPC, no large effects were observed upon lowering the pH of the system. The protein tilted 
toward the membrane surface in all of the simulations and the putative PrPSc oligomerization 
sites became inaccessible, thereby offering a possible protective mechanism against PrPSc-
induced misfolding of PrPC. 
 
  
  
 
3 
Abbreviations used 
MD  Molecular Dynamics 
TSE Transmissible spongiform encephalopathy 
PrP prion protein 
PrPC cellular prion protein, biologically active form 
PrPSc scrapie prion protein, infectious conformer 
CJD Creutzfeldt-Jakob disease  
BSE bovine spongiform encephalopathy  
GPI Glycosylphosphatidylinositol 
NMR Nuclear Magnetic Resonance Spectrometry 
DSSP Dictionary of secondary structure of proteins 
SASA Solvent accessible surface area 
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Introduction 
 Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases 
associated with misfolding of the prion protein (PrP). TSEs include a range of diseases in 
humans and other mammals, such as Creutzfeldt-Jakob disease (CJD) and bovine spongiform 
encephalopathy (BSE or mad cow disease). These diseases are caused by the misfolding of the 
prion protein from its native conformation (PrPC) to a disease-associated form (PrPSc) (Van der 
Kamp and Daggett, 2009; Prusiner et al., 1998; Gambetti et al., 2003). PrPC is a 
glycosylphosphatidylinositol (GPI) anchor membrane-bound protein and it is usually 
diglycosylated at Asn181 and Asn197 (DeArmond et al., 1997, 1999). The native structure of 
PrPC consists of a flexible N-terminal region (residues 23-127) and a structured C-terminal 
globular domain (residues 128-228). There are three helices – HA (residues 144-154), HB 
(residues 173-194), and HC (residues 200-228) – and two β-strands – S1 (residues 128-131) and 
S2 (residues 161-164) – in the structured globular domain (Figure 1). PrPC is presented at the cell 
surface of neurons, and it has been implicated in signal transduction (Mouillet-Richard et al., 
2000; Linden et al., 2008; Resenberger et al., 2011) and metal metabolism (Burns et al., 2003; 
Millhauser, 2007; Klewpatinond et al., 2008; Singh et al., 2009).  
 The central hypothesis of prion diseases is that they are protein-only diseases, whereby 
the prion protein is the only agent required for propagation and transmission of the disease 
(Prusiner et al., 1998). Recombinant PrP, which lacks glycans and the GPI anchor, is the primary 
construct used in experimental studies. However, non-protein moieties affect the disease process 
in vivo. The N-linked glycans influence PrP expression, distribution (within regions of the brain 
and among different types of neuronal cells) and deposition of PrPSc in vivo (DeArmond et al., 
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1997, 1999). The glycans have also been observed to modify the conformation of PrPC and/or 
affect the affinity of PrPC for a particular strain of PrPSc (Rudd et al., 1999; DeMarco and 
Daggett, 2005; Collinge et al., 1996; Safar et al., 1998). Nonetheless, based on the protein 
structure alone, recombinant PrPC appears to be a good model for biologically relevant forms of 
PrPC, because the structures of diglycosylated human PrPC and recombinant PrPC are similar, as 
indicated by circular dichroism (CD) and Nuclear Magnetic Resonance Spectrometry (NMR) 
(Hornemann et al., 2004). 
 Most of the molecular dynamics (MD) simulation studies of PrP only focus on the 
protein-only portion (PrPprot), i.e. the simulations include neither the posttranslational 
modifications nor the membrane environment. Various computational studies have been 
performed on PrPprot at acidic pH ranges (Alonso et al., 2001; Cheng and Daggett, 2014; Van der 
Kamp and Daggett, 2010). Experiments indicate that low pH cellular environments, such as 
endocytic organelles and lipid rafts, play a role in misfolding (Borchelt et al., 1992; Arnold et al., 
1995). In order to provide a more realistic simulation environment of PrPC to determine the pH 
effects on misfolding, it is necessary to include the non-protein moieties in simulations. 
 Thus far there has been only one membrane MD simulation study of GPI-anchored 
diglycosylated PrPC in which both PrPprot and the full scrapie-competent construct (i.e. with the 
N-terminus built on to the NMR fragment) including the membrane, glycans and GPI anchor 
(PrPmem) were simulated (DeMarco and Daggett, 2009). In this case the simulations were 
performed at neutral and low pH at 25C and they began with the protein perpendicular to the 
membrane to allow for interactions between the two to evolve naturally. However, the PrPmem 
simulations were only 15 ns. Here we build upon that work by performing multiple, longer 
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simulations that include the glycans, GPI anchor and lipid membrane at 37C to better explore 
the conversion pathway of PrPC and its structural dynamics under more physiological conditions. 
We performed simulations of the system in triplicate at low, mid, and neutral pH. Each PrPmem 
simulation was 80 ns long, increasing sampling time from 30 ns to 720 ns, and we have 750 ns of 
control free PrPC MD at this same temperature and pH regimes, for a total of ~1.5 s. With these 
new simulations we have both confirmed and extended our earlier findings and observed 
interactions between the protein and non-protein moieties that potentially modulate conversion 
of PrPC. We found that the structured C-terminal domain of PrP is more stable with glycans and 
membrane than without such non-protein moieties. The glycans did not form contacts with the 
membrane, but the Asn181 glycan formed contacts with the flexible N-terminus of PrP. In 
addition, PrP tilted towards the membrane such that the putative oligomerization sites on the 
protein were shielded by the membrane surface.  Our findings shed light on why conversion of 
PrPC to PrPSc is more efficient with the bare recombinant protein than with glycosylated, 
membrane-bound PrPC. 
Materials and Methods 
Starting structures of PrPprot and PrPmem 
 For PrPprot, the starting coordinates for the globular region (residues 125-228) were 
obtained from the human NMR structure (Zahn et al., 2000) (PDBID: 1QLX). The NMR 
structure was then extended to include residues 90-230; this longer construct is necessary 
because the N-terminal residues not present in the NMR structures are critical to infectivity and 
the shorter NMR construct is not scrapie competent. In order to model residues 90-230 of PrP, 
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the missing N-terminal residues were added to the structure such that the N-terminus extended 
away from the protein to avoid bias, as described previously (Van der Kamp and Daggett, 2010; 
DeMarco and Daggett, 2009). To construct PrPmem (Figure 1A), non-protein moieties of the 
system were added to the PrPprot system, as described previously (DeMarco and Daggett, 2009). 
Briefly, two 13-residue glycans were attached to Asn181 and Asn197. A triantennary glycoform 
scaffold common to mouse PrPC and PrPSc was chosen (Stimson et al., 1999). This glycan is 
representative of human N-glycans (Varki et al., 2003) (Figure 1B). This glycan contains one 
sialic group and the acid was deprotonated in all simulations as its pKa is ~2.5, which is below 
the pH regimes investigated here. The GPI anchor was attached to the C-terminus of PrP. Further 
details regarding building of the glycan and GPI components are provided by DeMarco and 
Daggett (2009). The GPI anchor was embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) membrane bilayer, which consists of 335 lipid-molecules. The lipid 
bilayer was modelled based on the structure built by the Schulten group (Heller et al., 1993). 
POPC was chosen as is has been identified as the most abundant lipid around PrP (Brugger et al, 
2004).  
MD simulations 
 For both PrPprot and PrPmem simulations, the starting structures were solvated in a pre-
equilibrated rectangular water box (Levitt et al., 1997) with a density of 0.993 g/ml, which is the 
experimental density for water at 37 °C (Kell, 1967). Detailed methods of the PrPprot simulations 
have been described previously (Van der Kamp and Daggett, 2010). For the PrPmem system 
simulations, the periodic box, which extended >20 Å from any solute atom above and below, had 
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the following dimensions: 94 × 98 × 147 Å. Neutral, mid, and low pH ranges were modelled by 
altering protonation states of histidine, aspartate, and glutamate residues, as described previously 
(Van der Kamp and Daggett, 2010). Unfortunately pKa values are not available for these groups, 
so the pH ranges fall in the following approximate ranges: neutral, pH ≥ ~6; mid, 4 ≤ pH ≤ 6; 
and low, 3 ≤ pH ≤ 4. These ranges are approximate and individual pKas can certainly differ from 
the ‘standard’ values, but this approach has correctly modeled pH-dependent conformational 
behavior in a variety of systems, including the prion protein. The Levitt et al. (1995) force field 
was employed for all MD simulations, and simulations were performed at 37 °C using in lucem 
molecular mechanics (ilmm) (Beck et al., 2000-2017) and standard procedures (Beck and 
Daggett, 2004). The lipid (Smolin et al, 2008) parameters have been presented previously and 
they were derived to be consistent with our force field.  For the PrPmem system, triplicate 
simulations were performed for each pH using a different random number seed, and each 
simulation was performed for 80 ns. Performing multiple independent simulations improves 
sampling over a single simulation (e.g. 3 x 80 ns should provide better sampling and improved 
probability of observing conformational transitions compared with a single simulation of 240 
ns). For the PrPprot
 system, five simulations were performed for each pH regime, and each 
simulation was 50 ns long. In total we have ~1.5 s of sampling: 720 ns for PrPmem and 750 ns 
for PrPprot. 
MD simulation analysis 
 Analyses such as, solvent accessible surface area (SASA), dictionary of secondary 
structure of proteins (DSSP), Cα root-mean square deviation (RMSD), and Cα root-mean square 
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fluctuation (RMSF) were performed with ilmm as previously described (Van der Kamp and 
Daggett, 2010). NOE restraint data (BMRB 4641) were obtained from human PrP E200K 
(Zhang et al., 2000). NOE restraint satisfaction of PrPmem simulations was measured for the 
combined simulations in each pH regime with ilmm. An NOE restraint was considered satisfied 
if the <r-6> weighted distance between the nearest protons associated with the NOE was less than 
the upper bound or 5 Å, whichever is greater. The HC tilt angle was measured between a vector 
fit through Cα atoms of residues 200-214 on HC and the x-y plane. The x-y plane was an 
approximation of the membrane surface. Heavy atom contacts were considered intact when two 
carbon atoms were ≤ 5.4 Å apart or when other interacting heavy atoms were ≤ 4.6 Å apart. The 
population of a contact (percentage time present over the simulation) was averaged across 
simulation replicates for each pH regime. The 40-80 ns of PrPmem simulations and the 10-50 ns 
time periods of PrPprot simulations were used to calculate the average contact occupancies.  
 
Statistics 
Data are presented as the mean and associated standard deviation. Overall statistics over time 
amounted to analysis of 1,500,000 time points (or structures). Statistical properties and 
frequencies over the specific time periods provided in the previous section included 40,000 
samples for each simulation.  
 
Results and Discussion 
 The starting structure of the PrPprot system (bare protein in water) was created using the 
human NMR PrPC structure (PDB:1QLX). The missing N-terminal residues 90-127 were added 
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to the structure, as they are important to PrP conversion and pathology (Swietnicki et al., 1997; 
Luhrs et al., 2006).  These N-terminal residues were built to extend away from the structured 
globular domain to avoid bias in sampling of the N-terminus, as described previously (Van der 
Kamp and Daggett, 2010; DeMarco and Daggett, 2009). The PrPmem system (including glycans, 
the GPI anchor and the membrane), in addition to the NMR structure, was created by placing PrP 
on a phosphatidylcholine (POPC) lipid bilayer (Figure 1A). The GPI anchor was embedded in 
the lipid bilayer and attached to the C-terminus of the PrP. Glycans were attached to the 
glycosylation sites at Asn181 and Asn197. Simulations of both the PrPprot and PrPmem systems 
were performed at neutral, mid and low pH. The pH environment was modeled by altering the 
protonation states of charged residues such that low pH corresponds to pH below the pKa of Asp 
and Glu (approximately pH 4), mid pH corresponds to pH above 4 and below the pKa of His, 
and neutral pH is above the pKa of His  (see Materials and Methods). All simulations were 
performed at 37 °C.  
Misfolding in Protein-only PrPC simulations 
 PrPprot simulations (without GPI anchor, glycans and membrane) at neutral, mid and low 
pH yielded structures that deviate significantly from the starting structure. The Cα root-mean 
square deviation (RMSD) was used to detect gross conformational changes in simulations. The 
average Cα RMSD for the globular domain (residues 128-228) for neutral, mid and low pH 
simulations were 2.12 ± 0.5 Å, 2.59 ± 0.38 Å and 2.96 ± 1.27Å, respectively, showing increasing 
structural changes upon lowering the pH. One of the major contributors to the increase in Cα 
RMSD at low pH was the HA helix region: the HA helix along with its preceding loop (S1-HA 
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loop) was displaced from its native position, resulting in significant disruption in hydrophobic 
contacts (Figure 2A,B). Such a conformational change was also observed in previous simulations 
of human PrP pathogenic mutants (Van der Kamp and Daggett, 2010; Cheng and Daggett, 2014; 
Chen et al., 2010) and low pH simulations of human PrP (Van der Kamp and Daggett, 2010). 
Hydrophobic packing is crucial to protein stability, and disruption of the S1-HA loop packing 
increases the aggregation tendency of PrP. In addition, detachment of the S1-HA loop from the 
HC helix is necessary for PrPSc fibrillation, as indicated in both in vitro (Eghiaian et al., 2007; 
Hafner-Bratkovic et al., 2011) and in vivo (Hafner-Bratkovic et al., 2011) disulfide engineering 
experiments. These experiments support our earlier hypothesis that PrPC misfolding involves the 
exposure of the hydrophobic S1-HA loop, with the formation of a new hydrophobic strand that is 
a site for PrPSc-oligomerization. We denoted this oligomerization site as the E4 strand (Figure 
2B), since it consistently forms an extended structure in simulations of various PrP species at low 
pH (Alonso et al., 2001; DeMarco and Daggett, 2004; DeMarco et al., 2006; Scouras and 
Daggett, 2008). 
 In addition to the E4 strand, another nonnative strand (denoted E1) forms at the N-
terminus in the PrPprot simulations (Figure 2C). The E1 strand was recruited by the native strand 
S1, and our previous simulations also have formed this E1 strand, which ranges from residues 
113-122 (DeMarco and Daggett, 2004; Scouras and Daggett, 2008; Alonso et al., 2001). We 
hypothesized that the formation of the E1 strand is another hallmark of PrP misfolding, and that 
the E1 strand is also a site for PrPSc-oligomerization. Our results are in agreement with 
experiments indicating that the PrP peptides within residues 106-127 of the N-terminus 
aggregate and form β-sheet-rich oligomers and fibrils (Lee et al., 2008; Silva et al., 2003; Walsh 
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et al., 2010; Cheng et al., 2011). Interestingly, a recent crystal structure of PrP in complex with a 
PrPSc-inhibitory nanobody also has an E1 strand consisting of N-terminal residues 118-122 
(Figure 2C) (Abskharon et al., 2014), lending further support to the MD-derived misfolded 
structures and our prediction and characterization of this strand before the structure was 
determined (Alonso et al., 2001). 
 In order to interpret our MD-derived misfolded PrPSc structures in the context of the 
oligomerization process, we have previously proposed the spiral model. In the spiral model, MD-
derived misfolded PrPSc structures were assembled by docking the E1 strand of one monomer to 
an adjacent neighbor at the E4 strand, and in this way the monomers are arranged along a three-
fold screw-axis (Figure 2D). The spiral model has been previously validated by various 
experimental data (DeMarco and Daggett, 2004; DeMarco et al., 2006), and recent experimental 
data on PrPSc soluble oligomers lend further support to our model (Cheng and Daggett, 2017, in 
preparation). 
 Although misfolding was observed in the PrPprot simulations, experiment indicates that 
membrane-bound PrPC is more resistant to misfolding, since neither acidic treatment (Baron et 
al., 2002) nor denaturants (Lin et al., 2013) have been shown to induce misfolding and 
oligomerization of membrane-bound PrPC. Furthermore, unlike bare recombinant PrP, 
membrane-bound PrPC appears to be resistant to PrPSc-induced misfolding unless it is released 
from membranes by phospholipase C digestion (Baron et al, 2002; Baron and Caughey, 2003). 
We hypothesize two possible mechanisms by which the posttranslational modifications and the 
membrane environment contribute to the misfolding-resistance: (1) the glycans and membrane 
environment provide contacts that stabilize the native structure of PrPC; and (2) the glycans and 
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membrane environment shield the putative oligomerization sites, strands E1 and E4, thereby 
providing a steric barrier to misfolding and oligomerization. In the following results from our 
PrPmem simulations, we evaluate the stability of PrP using Cα RMSD, Nuclear Overhauser Effect 
Crosspeak (NOE) satisfaction and contact analyses. Details regarding the contacts and relative 
positions between PrP and the glycans, and between PrP and the membrane, are also provided. 
We conclude by discussing how the glycans and the membrane may contribute to protective 
mechanisms against PrP misfolding. 
Conformational changes in PrPmem simulations 
 Gross conformational changes of PrP in the PrPmem simulations are reflected in the Cα 
RMSD relative to the starting structure. In all pH regimes, the average Cα RMSDs of the 
globular domain of PrP (residues 128-228) were within the range of 1.5-2.0 Å (Figure S1), 
reflecting the retention of the native-like globular domain structure. The Cα root-mean square 
fluctuations (RMSF) about the average structure after equilibration reflect the mobility of the 
protein. The Cα RMSF values of the residues in the globular domain were less than 2 Å in all pH 
regimes, whereas those of the residues in the flexible N-terminus were in the range of 2 – 5 Å 
(Figure S2). 
NOE satisfaction by PrPmem simulations 
 The PrP structures in the PrPmem simulations were compared to the Nuclear Overhauser 
Effect crosspeaks (NOE) reflecting the proximity of protons throughout the structure by 
comparing with the NOE restraints of the human PrP E200K mutant (Zhang et al., 2000), which 
is structurally similar to wild type human PrP, using a previously described method (Van der 
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Kamp and Daggett, 2010). The NOE restraints are available for residues 125-230, which cover 
the structured, helical domain. Structures from the neutral, mid, and low pH PrPmem simulations 
satisfied 88% of the 2641 NOEs, in all pH regimes. Therefore, PrP structures from our PrPmem 
simulations are similar to the NMR structures of human recombinant PrP regardless of the pH 
environment. This is in agreement with CD experiments that confirm that PrPC retains a helix-
rich native structure when bound to POPC vesicles (Sanghera and Pinheiro, 2002). 
Acidic pH effects on PrPmem simulations 
 There were contact differences in acidic and neutral pH simulations (Table S1). The mid 
pH simulations lost the Glu152-His155 contact when the His140-Asp147 as well as other 
interactions formed. As for the low pH simulations, only two residue contacts were significantly 
disrupted: Leu125-Ile182 and Tyr157-Phe198. The Leu125-Ile182 contact was affected 
primarily by the loss of a hydrogen bond between side chains of Tyr128 and Asp178 upon 
protonation of the Asp. As for the Tyr157-Phe198 contact, Phe198 became more exposed and 
lost hydrophobic packing with Tyr157. As a consequence of these changes residues 154-157 at 
the C-terminus of HA lost helicity in both the mid and low pH simulations compared to neutral 
pH (Table S1).  These minor structural and intramolecular contact changes were all directly 
affected by the protonated residues at mid and low pH. These contact changes were localized and 
did not have a significant impact on the structure, as indicated by the globular Cα RMSD (Figure 
S1). These results are consistent with experiment, which indicates that low pH misfolding is 
inefficient for membrane-bound PrP (Baron et al., 2002). 
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PrPmem vs PrPprot: Major differences in intramolecular interactions 
 There were three PrP regions with significant contact differences between PrPmem and 
PrPprot simulations: the Phe198 hydrophobic pocket, the native sheet packing with the HB and 
HC helices, and the packing between HC and the S1-HA loop. A list of relevant contact 
occupancies are provided in Table S2. Overall, the contacts in the PrPmem simulations were much 
more stable than those in PrPprot. These three areas that differ are discussed in detail below. 
 In the PrPmem simulations, Phe198 was buried and its average side chain solvent 
accessible surface area (SASAs) for neutral, mid, and low pH simulations was only 4, 13, and 19 
Å2, respectively. On the other hand, the SASA of Phe198 in the PrPprot simulations was at least 
three to four times greater (Figure S3). As Phe198 became exposed, the contacts between Phe198 
and Met206 were lost in the mid and low pH PrPprot simulations. The exposure of Phe198 was 
accompanied by the formation of the nonnative His187-Asp202 salt bridge. The side chains of 
His187 and Asp202 occupied the native side chain position of Phe198 (Figure 3A). This 
nonnative salt bridge kept the side chain of Phe198 in a solvent exposed conformation, which is 
consistent with our previous PrPprot simulations (Van der Kamp and Daggett, 2010). On the other 
hand, in all PrPmem simulations, Phe198 retained stable core contacts with neighboring residues, 
including His187 and Met206. The side chain motion of Phe198 was deterred by the bulky 
glycan attached to Asn197. As a result, the side chain of Phe198 remained buried in between HB 
and HC in all PrPmem simulations. 
 In all PrPmem simulations, the native S2 strand was tightly packed to HB and HC, such 
that Thr183 formed a stable contact with Gln160 (Figure 3B). The residue contact between 
Gln160 and Met213 on HC was populated on average >80% of the time in the neutral and mid 
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pH PrPmem simulations (Table S1), but this interaction was less stable in the low pH simulations 
(36% occupancy). On the other hand, all of the PrPprot simulations, regardless of pH, showed a 
significant loss in both Gln160-Thr183 and Gln160-Met213 contacts. Other than the packing 
between S2 and the helices HB and HC, there were two hydrogen bonds that contributed to the 
stability of this region: Tyr128-Asp178 and Tyr162-Thr183. The side chain of Tyr128 on S1 
stabilized the native sheet by hydrogen bonding to the side chain of Asp178 on HB (Figure 3B). 
As for the side chain of Thr183, it hydrogen bonded with the backbone amide of Tyr162 (Figure 
3B).  These hydrogen bonds were more prevalent in PrPmem simulations than PrPprot simulations. 
Overall, the native sheet in PrPmem formed stable packing interactions and hydrogen bonds while 
such interactions were lost in the PrPprot simulations. 
 Contacts in the S1-HA loop were more variable due to the conformational flexibility of 
this loop. One of the relatively robust contacts formed in PrPmem simulations was Arg136-
Val209, in which the hydrophobic portion of the side chain of Arg136 packed against the side 
chain of Val209 on HC (Figure 3C). In PrPprot, however, this contact was diminished and highly 
variable across simulations. Such loss of contacts between S1-HA loop and HC was expected, 
since the HA helix of the low pH PrPprot simulations was highly mobile and occasionally 
detached from HC (Figure S4). 
Interactions between the membrane and the flexible N-terminus 
 The flexible N-terminus (residues 90-127) formed contacts with the membrane surface in 
the PrPmem simulations (Figure S5). As can be seen in Figure S5, The N-terminus made extensive 
contacts with the membrane with respect to both the number of residues involved and the extent 
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of time that contacts were formed in all simulations at mid and low pH. This was also the case in 
two of the three simulations at neutral pH. As an illustration of the particularly prevalent 
interactions, His96 and Lys101 each formed long-lasting salt bridges with the phosphate groups 
on the membrane surface at low and mid pH (Figure 4A,B). These two positively charged 
residues are within residues 90-110, which represent one of the charged clusters of PrP (Wang et 
al., 2010). These charge clusters are important for electrostatic interactions involved in 
membrane association (Boland et al., 2010). At acidic pH, PrP binds to anionic lipids with higher 
affinity (Morillas et al., 1999). The pH effect was observed in our simulations, as reflected in the 
heightened interactions with the membrane at mid and low pH (Figure S5), and illustrated more 
specifically for a stable salt bridge between the doubly-protonated His96 with a phosphate group 
on the membrane (Figure 4A). 
Interactions between the glycans and the flexible N-terminus 
 The N-terminus of PrP interacted with the Asn181 glycan via Lys residues, but not with 
the Asn197 glycan. For example, at neutral pH, Lys101 formed stable contacts with the Asn181 
glycan (Figure 5A), preventing the N-terminus from forming contacts with the membrane 
(Figure S5). At mid pH, Lys104 also formed stable contacts with the Asn181 glycan in a similar 
conformation (Figure 5B). At low pH, Lys104 bound to the Asn181 glycan in a conformation 
different from that of the neutral and mid pH simulations, but with the same effect (Figure 5C). 
 Such consistent interactions between lysine residues and the Asn181 glycan were 
surprising and heretofore unrecognized. However, it is known that the charge clusters at the 
flexible N-terminus of PrP are important for binding glycosaminoglycans (GAGs), such as 
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heparin, chondroitin sulfate, and hyaluronic acid (Pan et al., 2002). Given the similar constituents 
of GAGs and glycans, it is reasonable to expect that the charge cluster of the flexible N-terminus 
can bind to the glycans, as indicated in our simulations. Glycosylation of PrP impedes the 
conversion efficiency in in vitro conversion assays (Priola and Lawson, 2001). While these large 
glycans can sterically inhibit PrPSc-induced misfolding, our results suggest that glycans can also 
bind to N-terminal lysine residues, thereby deterring the N-terminus from forming the E1 strand, 
which is a hallmark for misfolding in our MD-simulated conversion. Other than retardation of 
the misfolding process, glycans also play a complicated role in prion propagation (Zahn et al., 
2000). Given that the glycans can form stable interactions with the flexible N-terminus of PrP, 
different glycans may induce different N-terminal conformations, thus influencing strain-specific 
prion propagation, which is sensitive to conformational changes in PrPSc. Another complication 
is that while the glycans appear to stabilize and deter conversion of PrPC, the glycans are also 
involved in recognition and targeting of PrPSc to PrPC glycoforms in different regions of the 
brain (DeArmond et al., 1999). Unfortunately, the PrPC simulations presented here cannot 
directly address potential PrPC-PrPSc interactions, but our results suggest that the glycans have a 
number of effects on PrPC as well as its interactions with PrPSc. While speculative, PrPSc binding 
may compete with favorable glycan-PrPC interactions; MD simulations investigating these 
possible mechanisms are in progress.   
Tilting of the structured C-terminal domain on the membrane 
 In all of the PrPmem simulations, PrP tilted toward the membrane. For example, the angle 
between HC and the membrane surface dropped from 90 to ~30o by the end of the simulations 
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(Figure 6A,B). This tilting motion placed the putative E1 and E4 oligomerization sites on or very 
near the membrane surface. Exposure of residues 135-140 (the E4 region) was probed, and in 
low pH simulation 1, as an example, its exposure dropped from ~500 Å2 to < 200 Å2 by 45 ns. 
This significant reduction was due to the tilting motion of PrP, which buried the E4 epitope 
(Figure 6B). This tilted conformation was stable and buried the E4 epitope around 45 ns and 
remained as such until the end of the simulation. The other putative oligomerization site, the E1 
strand, was formed only in low pH simulation 3 (Figure 7). However, with a 30o tilt, the E1 
strand was buried on the membrane surface. We hypothesize that the tilting motion of 
membrane-bound PrPC retards PrPSc-induced misfolding by masking putative oligomerization 
sites on PrPC (Figure 8). Experiments broadly support this hypothesis, given that membrane-
bound PrP is more resistant to misfolding than free PrP (Baron et al., 2002; Baron and Caughey, 
2003). In addition, an antibody that targets residues 138-141 shows significantly decreased 
binding of membrane-bound PrPC compared with soluble PrPC (Leclerc et al., 2003), consistent 
with steric occlusion of E4 in the MD simulations. 
Conclusions 
 Overall, the PrPmem simulations were extremely stable and preserved a native-like PrP
C 
structure in all pH regimes, unlike the PrPprot simulation of free unglycosylated PrP
C. In most of 
the PrPmem simulations, the flexible N-terminus formed sporadic contacts with the membrane 
except for a few lysine and histidine residues in the N-terminus that formed stable salt bridges 
with the phosphate groups on the membrane. The glycans may modulate the misfolding process 
by interfering with E1 formation at the N-terminus through direct contacts with lysine residues at 
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the N-terminus. The tilting motion of membrane-bound PrP buried the E1 and E4 regions, both 
of which are putative oligomerization sites. This led us to hypothesize that the tilted 
conformation of membrane-bound PrPC protects critical regions of PrPC and deters PrPSc-induced 
misfolding, explaining why recombinant PrPC converts more readily. 
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Figure Legends 
Figure 1. PrPmem system used for MD simulations.  (A) Cyan and purple colored surfaces are 
the glycans attached to Asn181 and Asn197, respectively. The GPI anchor is represented as the 
light-blue surface. HA (residues 144-154), N-terminus (residues 90-127), S1 and S2 (residues 
128-131 and 161-164) are colored in cyan, green, and yellow, respectively. The HB (residues 
173-194) and HC (residues 200-228) helices are in blue. Remaining loop regions are colored 
gray. The carbon and oxygen atoms of the phosphatidylcholine (POPC) molecules are indicated 
as thin cyan and red lines, respectively. Nitrogen and phosphorus atoms are indicated by blue 
and brown spheres, respectively. The water is not displayed. (B) Schematic depiction of 
individual residues in the glycan attached to Asn 181 and Asn 197. 
Figure 2. Misfolding in PrPprot simulations.  (A) Left: starting structure. Right: helix HA 
structure for the last 25 ns of all PrPprot simulations at 1 ns granularity. Structures were aligned to 
the starting structure at the stable core residues 174-186 and 200-219, as shown in blue. Cyan, 
orange, and red cartoons represents structures from neutral, mid and low pH simulations, 
respectively. (B)  Left: starting structure. Right: mid pH simulation 3 at 49.9 ns. Hydrophobic 
residues 134, 137, 139, 141, 205, 209 and 213 are shown with translucent surface and stick 
representations of the side chains. E4 region is colored in orange. (C) Formation of the E1 strand 
(in red). Left: crystal structure (PDBID: 4KML (Abskharon et al., 2014)). Right: a representative 
MD-derived misfolded structure from PrPprot simulations. (D) An MD-derived converted PrP
Sc 
structure was used to construct a threefold screw-axis spiral model. The oligomerization site 
occurs between the E1 and E4 strands of the adjacent monomers. The structures are not to scale 
with panels A-C. 
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Figure 3 Differences between PrPmem and PrPprot simulations.  Structures are taken from mid 
pH simulations. Relevant residue contact occupancies are displayed. Standard deviations are 
computed for both PrPmem and PrPprot (For each pH, n = 3 for PrPmem, and n = 5 for PrPprot).  (A) 
Phe198 hydrophobic pocket. The black oval indicates the nonnative salt bridge that formed in 
PrPprot simulation. (B) Native sheet packing with HB and HC. The black ovals indicate the loss 
of hydrogen bonds in PrPprot simulations. (C) S1-HA loop packing with HC. The S1-HA loop 
detaches from HC and loses hydrophobic packing in PrPprot. 
Figure 4. Contacts between N-terminus and the membrane surface at mid and low pH.  
Contacts between residues 90-117 and the membrane are shown on the right. (A) Structure of 
membrane-bound PrP in mid pH simulation 3 at 80 ns. His96 formed a stable salt bridge with 
phosphate head group on the membrane. (B) Structure of membrane-bound PrP in low pH 
simulation 2 at 80 ns. Lys106 formed stable salt bridge with phosphate head group on the 
membrane. 
Figure 5.  Contacts between the Asn183 glycan and lysine residues at the flexible N-
terminus. Contacts between residues 90-117 and the Asn181 glycan are shown in the right 
column. Relevant lysine residues, N-acetylneuraminate (NeuNAc), galactose (Gal), N-
acetylglucosamine (GlcNAc), and fucose (Fuc) are shown as sticks. (A) Neutral pH simulation 3 
at 80 ns. (B) Mid pH simulation 2 at 80 ns. (C) Low pH simulation 3 at 80 ns. 
Figure 6.  PrP tilting on the membrane protecting the E4 putative oligomerization site.  (A) 
HC tilt angle for PrPmem simulation 1 (blue), 2 (green) and 3 (orange) at neutral, mid and low pH. 
(B) Before and after the tilting motion in low pH simulation 1. 
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 Figure 7.  Buried E1 epitope putative oligomerization site.  (A) Structure of the membrane-
bound PrP in low pH simulation 3 at 80ns. The orange epitope is E1, which is buried on the 
membrane surface in grey. (B) Secondary structure of the simulation over time. 
Figure 8.  Schematic of PrP conversion. Without glycans and the membrane environment, 
PrPprot misfolds and both E1 and E4 strands are accessible, allowing for oligomerization. As for 
PrPmem, the oligomerization sites E1 and E4 are buried or near the membrane surface, which 
would interfere of PrPSc to PrPC and propagation of PrPSc.   
 
 
